Abstract
Advanced glycation end products (AGEs) are known to play a pivotal role in the development of diabetes and its complications. Adipocytokines are important mediators of inflammatory and immune responses. The aim of this study was to investigate the correlation between serum levels of adipocytokines and AGEs in diabetic and non-diabetic patients with myocardial infarction. In the present study, serum leptin, serum adiponectin, interleukin-6 (IL-6), IL-8, tumor necrosis factor-α (TNF-α) and serum AGEs were investigated. Human serum samples of normal older subjects (n = 31), diabetic patients without myocardial infarction (n = 33), older diabetic patients with myocardial infarction (n = 32) and older non-diabetic with myocardial infarction (n = 30) were investigated. The patients were selected on clinical grounds from the National Institute of Cardiovascular Disease and the Jinnah Postgraduate Medical Centre, Karachi, Pakistan. Values of leptin, IL-6, IL-8, TNF-α and serum AGEs were significantly increased (P < 0.001) in diabetic and non-diabetic patients with and without myocardial infarction as compared with older healthy control subjects. Values of adiponectin were significantly decreased (P < 0.001) in diabetic and non-diabetic patients with and without myocardial infarction as compared with older healthy control subjects. Positive significant correlation was found between fasting blood glucose and serum AGEs, body mass index (BMI) and TNF-α, BMI and leptin, IL-6 and leptin, and IL-6 and TNF-α in all groups. A significant positive correlation was observed between systolic blood pressure and serum AGEs in older diabetic and non-diabetic patients with or without myocardial infarction. Negative significant correlation was found between BMI and adiponectin and IL-6 and adiponectin in all groups. Taken together, these findings demonstrate adipocytokines and AGEs levels were correlated with myocardial infarction in diabetic and non-diabetic patients suggesting its key role in the mechanism that links myocardial infarction.
Similar content being viewed by others
References
A.G. Pitas, N.A. Joseph, A.S. Greeberg, Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 89, 447–452 (2004)
A. Dominguez-Rodriguez, P. Avanzas, L. Consuegra-Sanchez, A. Sanchez-Grande, P. Abreu-Gonzalez, P. Conesa-Zamora, Inflammatory markers in blood and thrombus aspirated from patients with acute myocardial infarction with ST-segment elevation. ARTERIA trial study design and rationale. Biomarkers 18(4), 369–372 (2013)
M. Coelho, T. Oliveira, R. Fernandes, Biochemistry of adipose tissue: an endocrine organ. Arch. Med. Sci 9(2), 191–200 (2013)
M.J. Wen, C.H. Hsieh, C.Z. Wu, F.C. Hsiao, T.L. Hsia, Y.J. Hung, D. Pei, The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: a pilot study. Obes. Res. Clin. Pract. 7(3), e206–e210 (2013)
S. Hu, W. He, Z. Liu, H. Xu, G. Ma, The accumulation of the glycoxidation product N(ε)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease. Tohoku J. Exp. Med. 230(1), 25–32 (2013)
S.J. Yang, S. Kim, S.Y. Hwang, T.N. Kim, H.Y. Choi, H.J. Yoo, J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi, K.M. Choi, Association between sRAGE, esRAGE levels and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography. Atherosclerosis 220, 402–406 (2012)
B.K. Rodino-Janeiro, A. Salgado-Somoza, E. Teijeira-Fernandez, J.R. Gonzalez-Juanatey, E. Alvarez, S. Eiras, Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease. Eur. J. Endocrinol. 164, 529–537 (2011)
M.S. Runge, K. Molnar, N.R. Madamanchi, “Old” hearts and arteries: the role of oxidative stress, Trans. Am. Clin. Climatol. Assoc. 121, 52–60 (2010)
P.M. Ridker, Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr. Rev. 65, S253–S259 (2007)
K. Steyn, K. Sliwa, S. Hawken, P. Commerford, C. Onen, A. Damasceno, S. Ounpuu, S. Yusuf, INTERHEART Investigators in Africa, Risk factors associated with myocardial infarction in Africa: the Interheart Africa Study. Circulation 112, 3554–3561 (2005)
M. Peppa, J. Uribarri, H. Vlassara, The role of advanced glycation end products in the development of atherosclerosis. Curr. Diabetes Rep. 4, 31–36 (2004)
M.M. Gabir, J. Roumain, R.L. Hanson, D. Dabelea, G. Imperatore, J. Roumain, P.H. Bennett, W.C. Knowler, The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23, 108–112 (2000)
Y. Ono, S. Aoki, K. Ohnishi, T. Yasuda, K. Kawano, Y. Tsukada, Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res. Clin. Pract. 41, 131–137 (1998)
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, P.A. Tataranni, Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86(5), 1930–1935 (2001)
B.B. Dokken, The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids. Diabetes Spectr. 21(3), 160–165 (2008)
H.J. De Las, F. Bacha, H. Tfayli, Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm. Res. Paediatr. 76, 379–385 (2011)
I.F. Shatat, K.D. Freeman, P.M. Vuguin, Relationship between adiponectin and ambulatory blood pressure in obese adolescents. Pediatr. Res. 65, 691–695 (2009)
M. Lambert, J. O’Loughlin, E.E. Delvin, Association between insulin, leptin, adiponectin and blood pressure in youth. J. Hypertens. 27, 1025–1032 (2009)
J.M. Cook, R.K. Semple, Hypoadiponectinemia—cause or consequence of human “insulin resistance”? J. Clin. Endocrinol. Metab. 95, 1544–1554 (2010)
D.C. Lau, B. Dhillon, H. Yan, Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 288, H2031–H2041 (2005)
S.F. Yan, R. Ramasamy, Y. Naka, A.M. Schmidt, Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ. Res. 93, 1159–1169 (2003)
H.J. Park, J.Y. Baek, W.S. Shin, D.B. Kim, S.W. Jang, D.I. Shin, Y.S. Koh, S.M. Seo, J.S. Uhm, T.H. Kim, C.J. Kim, P.J. Kim, K. Chang, W.S. Chung, K.B. Seung, J.M. Lee, Soluble receptor of advanced glycated endproducts is associated with plaque vulnerability in patients with acute myocardial infarction. Circ. J. 75, 1685–1690 (2011)
G. Basta, S. Del Turco, F. Marchi, T. Navarra, D. Battaglia, A. Mercuri, A. Mazzone, S. Berti, Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I. Coron. Artery Dis. 22, 590–594 (2011)
R. Shibata, K. Sato, D.R. Pimentel, Y. Takemura, S. Kihara, K. Ohashi, T. Funahashi, N. Ouchi, K. Walsh, Adiponectin protects against myocardial ischemia reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096–1103 (2005)
A.L. Pasqui, M. Di Renzo, G. Bova, S. Maffei, G. Pompella, A. Auteri, L. Puccetti, Proinflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin. Exp. Med. 6, 38–44 (2006)
A. Bossowska, B. Kiersnowska-Rogowska, A. Bossowski, B. Galar, P. Sowiński, Cytokines in patients with ischaemic heart disease or myocardial infarction. Kardiol. Pol. 59, 110–114 (2003)
K. Mizia-Stec, Z. Gasior, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, I. Kobielusz-Gembala, Serum tumor necrosis factor-alpha, interleukin-2 and interleukin-10 activation instable angina and acute coronary syndromes. Coron. Artery Dis. 14, 431–438 (2003)
Y. Luo, D. Jiang, D. Wen, J. Yang, L. Li, Changes in serum interleukin-6 and C-reactive protein levels in patients with acute coronary syndromes and their responses to simvastatin. Heart Vessels 19, 257–262 (2004)
H. Koukkunen, K. Penttila, A. Kemppainen, M. Halinen, I. Penttila, T. Rantanen, K. Pyörälä, C-reactive protein, fibrinogen, IL-6, and TNF-alpha in the prognostic classification of unstable angina pectoris. Ann. Med. 33, 37–47 (2001)
Y.N. Wang, S.M. Che, H.Q. Ma, Clinical significance of IL-1 beta, sIL-2R, IL-6, TNF-alpha and IFN-gamma in acute coronary syndromes. Chin. Med. Sci. J. 19, 120–124 (2004)
T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, E.B. Rimm, Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291, 1730–1737 (2004)
S. Kojima, T. Funahashi, T. Sakamoto, S. Miyamoto, H. Soejima, J. Hokamaki, I. Kajiwara, S. Sugiyama, M. Yoshimura, K. Fujimoto, Y. Miyao, H. Suefuji, A. Kitagawa, N. Ouchi, S. Kihara, Y. Matsuzawa, H. Ogawa, The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89(6), 667–668 (2003)
N. Ouchi, S. Kihara, Y. Arita, K. Maeda, H. Kuriyama, Y. Okamoto, K. Hotta, M. Nishida, M. Takahashi, T. Nakamura, S. Yamashita, T. Funahashi, Y. Matsuzawa, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473–2476 (1999)
S. Plant, B. Shand, P. Elder, R. Scott, Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diabetes Vasc. Dis. Res 5, 102–108 (2008)
N. Ouchi, S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, K. Hotta, M. Nishida, M. Takahashi, M. Muraguchi, Y. Ohmoto, T. Nakamura, S. Yamashita, T. Funahashi, Y. Matsuzawa, Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102(11), 1296–1301 (2000)
R. Ouedraogo, X. Wu, S.Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, B.J. Goldstein, Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840–1846 (2006)
P. Libby, P.M. Ridker, A. Maseri, Inflammation and atherosclerosis. Circulation 105(9), 1135–1143 (2002)
Y. Unno, M. Sakai, Y. Sakamoto, A. Kuniyasu, H. Nakayama, R. Nagai, S. Horiuchi, Advanced glycation end products-modified proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via CD36. Biochem. Biophys. Res. Commun. 325, 151–156 (2004)
F. Sam, K. Walsh, What can adiponectin say about left ventricular function? Heart 96(5), 331–332 (2010)
Acknowledgment
This work was financially supported by Pakistan Science Foundation Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Memon, A.G., Rahman, M.A., Alghasham, A. et al. Correlation between adipocytokines and AGE products in diabetic and non-diabetic patients with myocardial infarction. Res Chem Intermed 41, 1625–1634 (2015). https://doi.org/10.1007/s11164-013-1298-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-013-1298-6